Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001193125-26-343077

SVP, CFO acquired 638 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Taylor Daphne SVP, CFO 2026-08-06 Option exercise +638 638 D
Derivatives
Taylor Daphne SVP, CFO 2026-08-06 Option exercise · Restricted Stock Unit −638 0 D
Loading xslF345X06/ownership.xml…